Register entry
- Registered sites
- 0
- Active NDC listings
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
22 active NDC listings: 2 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 2.
| Dosage form | NDCs |
|---|---|
| capsule, delayed release | 2 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| takeda gmbh, oranienburg | 2 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | dexlansoprazole | capsule, delayed release | 47234-1147DRUG FOR FURTHER PROCESSING |
| - | dexlansoprazole | capsule, delayed release | 47234-1148DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing dexlansoprazole
- Takeda Pharmaceuticals U.S.A., Inc.7 sites · 226 NDC
- International Medication Systems, Ltd.3 sites · 2,801 NDC
- Bryant Ranch Prepack1 site · 4,357 NDC
- Golden State Medical Supply Inc.1 site · 670 NDC
- Jubilant Biosys Limited1 site · 94 NDC
- Aphena Pharma Solutions - Tennessee, LLC0 sites · 795 NDC
- Mylan Pharmaceuticals, Inc.0 sites · 489 NDC
- Upsher-Smith Laboratories, Inc.0 sites · 230 NDC
Enquiry
Common questions
- Is Takeda GmbH, Oranienburg FDA approved?
- Takeda GmbH, Oranienburg holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Takeda GmbH, Oranienburg make?
- 2 products are listed under Takeda GmbH, Oranienburg in the openFDA NDC Directory, most often as capsule, delayed release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.